Examkin

Soru

Zorluk: OrtaPreventive Care and Screening

A 55-year-old man presents to the clinic for a routine health maintenance visit. His medical history is significant for type 2 diabetes mellitus and primary hypertension. He has a 30-pack-year smoking history and continues to smoke half a pack of cigarettes daily. His surgical history is unremarkable. His last colonoscopy was performed exactly 10 years ago at age 45 and was normal. His immunizations are up to date, including an annual influenza vaccine, a Tdap booster 2 years ago, and a completed recombinant zoster vaccine series at age 50. He has never received a pneumococcal vaccine. His records show a negative one-time hepatitis C antibody test at age 50. He has no specific health complaints, new skin lesions, or vision changes today.

Based on current United States Preventive Services Task Force (USPSTF) and Advisory Committee on Immunization Practices (ACIP) guidelines, which of the following preventive interventions are indicated for this patient today? (Select all that apply)

  1. A
    Routine screening for melanoma with a total body clinical skin examination
  2. Screening for lung cancer with low-dose computed tomography (LDCT)Cevap
  3. Screening for colorectal cancer with colonoscopyCevap
  4. Administration of the 20-valent pneumococcal conjugate vaccine (PCV20)Cevap
  5. E
    Repeat screening for hepatitis C virus (HCV) antibody

Cevap

The indicated interventions are screening for lung cancer with low-dose computed tomography (LDCT), screening for colorectal cancer with colonoscopy, and administration of the 20-valent pneumococcal conjugate vaccine (PCV20).
This patient requires multiple preventive interventions based on his age, comorbidities, and social history. According to USPSTF guidelines, annual lung cancer screening with low-dose computed tomography (LDCT) is recommended for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or have quit within the past 15 years. This 55-year-old current smoker with a 30 pack-year history meets these criteria. Furthermore, colorectal cancer screening is recommended for average-risk adults aged 45 to 75. Because his last normal colonoscopy was exactly 10 years ago, he is due for repeat screening. Finally, ACIP guidelines state that adults aged 19 to 64 years with certain underlying medical conditions, such as diabetes mellitus and cigarette smoking, should receive a pneumococcal vaccine. As he is vaccine-naive for pneumococcus, administration of the 20-valent pneumococcal conjugate vaccine (PCV20) is indicated.

Adım Adım Çözüm

1
Assess the patient's age and smoking history to determine lung cancer screening eligibility.
The patient is 55 years old, has a 30-pack-year smoking history, and is a current smoker.
USPSTF guidelines require LDCT screening for adults aged 50-80 with a >=20 pack-year history who currently smoke or quit within 15 years.
2
Evaluate the need for colorectal cancer screening.
The patient is 55 and his last normal colonoscopy was 10 years ago.
Standard screening interval for average-risk adults following a normal colonoscopy is 10 years.
3
Review the patient's immunization history and comorbid conditions.
He has diabetes mellitus, is an active smoker, and has never received a pneumococcal vaccine.
ACIP recommends PCV20 for adults 19-64 with specific risk factors such as diabetes or smoking.
4
Evaluate the remaining options against guidelines.
Routine visual skin exam and repeat HCV screening without new risk factors are not routinely recommended by the USPSTF.
Skin cancer screening has insufficient evidence; HCV screening is generally a one-time test for average-risk adults.

Anahtar Kavram

Application of age- and risk-based USPSTF screening and ACIP immunization guidelines for adults in the primary care setting.
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru